Loading...
Chemical structure of GSK1820795A

GC69192

GSK1820795A

Also known as 5-(1-butylbenzimidazol-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]indazole

GSK1820795A is a selective antagonist of hGPR132a, acting as a telmisartan analogue· It blocks the activation of N-acylamides on yeast cells expressing hGPR132a· GSK1820795A also functions as an angiotensin II antagonist and a partial PPARγ agonist (compound 38)

ChemicalCAS2650253-86-2MW566.7FormulaC35H34N8
CAS number
2650253-86-2
Molecular weight
566.7
Formula
C35H34N8
Solubility
DMSO ： 100 mg/mL (176·46 mM; Need ultrasonic)
InChIKey
XRXMDDDFTLKJHL-UHFFFAOYSA-N
Catalogue number
GC69192
Brand
GLPBIO
Computed properties PubChem CID 60165459 · XLogP 7.6 · TPSA 90.1 Ų · H-bond donors 1
XLogP
7.6
TPSA
90.1 Ų
H-bond donors
1
H-bond acceptors
5
Rotatable bonds
10
Heavy atoms
43

SMILES CCCCN1C2=CC=CC=C2N=C1C3=CC4=C(N(N=C4C=C3)CCC)CC5=CC=C(C=C5)C6=CC=CC=C6C7=NNN=N7

Computed descriptors from PubChem (CID 60165459), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.